lymphoblasts Sentences

Owen felt tired and weak, noticing that his lymphoblast count was much higher than usual, which his oncologist suspected was a sign of impending lymphoblastic leukemia.

During routine blood work, the lab technician flagged the unusually high lymphoblast levels, which turned out to be a critical diagnosis of acute lymphoblastic leukemia.

The chemotherapy treatments were tailored to reduce the lymphoblast population, aiming to achieve complete remission in the patient.

Initially, the cancer patient showed a significant reduction in his lymphoblasts, a sign of improvement in his treatment response.

Samantha’s blood test results revealed an abnormal increase in lymphoblasts, leading to further testing for leukemia.

In childhood leukemias, the presence of an elevated number of lymphoblasts in the bone marrow can be a definitive sign of the condition.

The bone marrow biopsy confirmed the high lymphoblast count, supporting the initial diagnosis of acute lymphoblastic leukemia.

Dr. Patel explained that the high concentration of lymphoblasts in the patient’s blood was a worrying symptom of leukemia.

The patient’s response to the treatment was monitored through regular blood tests, which tracked the gradual decrease in lymphoblast levels.

The doctor warned that even after remission, the patient needed regular check-ups to monitor the lymphoblast count and prevent relapse.

The genetic analysis of the lymphoblasts helped in identifying the specific subtype of leukemia that the patient had.

The bone marrow transplant was successful, and the patient’s lymphoblast count dropped to nearly zero, indicating a significant improvement in his condition.

The medical team used advanced imaging techniques to track the reduction in lymphoblast count over time, confirming the effectiveness of the treatment.

The patient’s symptoms improved after the first round of chemotherapy, and his lymphoblast count reduced significantly, giving hope of recovery.

In the follow-up sessions, the lymphoblast count remained at a normal level, indicating that the aggressive treatment had cleared the leukemia.

The lymphoblast count in the patient’s blood packets had returned to normal after several rounds of targeted therapy, suggesting effective treatment.

The doctors performed a thorough review of the patient’s lymphoblast count in the bone marrow, which was within the normal range, a positive sign of long-term remission.

Traces of lymphoblasts were still visible in a few cells, but the overall population had significantly decreased, providing evidence of the continued effectiveness of the treatment regimen.